← Back to Search

Mindfulness ecological momentary intervention for Generalized Anxiety Disorder

N/A
Recruiting
Led By Nur Hani Zainal, M.S.
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 14-day post-treatment
Awards & highlights

Study Summary

This trial is testing the efficacy of a 14-day smartphone mindfulness intervention for people with generalized anxiety disorder, compared to a self-monitoring placebo group. The primary outcome measures are reductions in worry and negative perseverative cognitions, and increases in attentional control and executive functioning.

Eligible Conditions
  • Generalized Anxiety Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 14-day post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 14-day post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety Disorders
Anxiety Disorders
Change from Baseline Perseverative Cognitions at 14-Day Post-Treatment
+1 more
Secondary outcome measures
Change from Baseline Attentional Control at 14-Day Post-Treatment
Change from Baseline Attentional Control at 6-Week Post-Randomization
Mental Depression
+15 more
Other outcome measures
Psychiatric Rehabilitation

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Mindfulness ecological momentary interventionExperimental Treatment1 Intervention
The SMP condition was developed to parallel the treatment while eliminating its theorized active therapeutic elements - open monitoring, acceptance, attending to small moments, breathing retraining, continual practice of mindfulness. Therefore, it did not mention anything about mindfulness at all. Instead, SMP participants were instructed to notice their cognitions and emotions and how distress they might be. No instruction on accepting their thoughts and feelings as they are were given.
Group II: Self-monitoring placeboPlacebo Group1 Intervention
The SMP condition was developed to parallel the treatment while eliminating its theorized active therapeutic elements - open monitoring, acceptance, attending to small moments, breathing retraining, continual practice of mindfulness. Therefore, it did not mention anything about mindfulness at all. Instead, SMP participants were instructed to notice their cognitions and emotions and how distress they might be. No instruction on accepting their thoughts and feelings as they are were given.

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor
357 Previous Clinical Trials
125,687 Total Patients Enrolled
3 Trials studying Generalized Anxiety Disorder
174 Patients Enrolled for Generalized Anxiety Disorder
Nur Hani Zainal, M.S.Principal InvestigatorThe Pennsylvania State University
~46 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top